中华护理杂志 ›› 2023, Vol. 58 ›› Issue (7): 808-815.DOI: 10.3761/j.issn.0254-1769.2023.07.006
收稿日期:
2022-08-23
出版日期:
2023-04-10
发布日期:
2023-04-11
通讯作者:
胡雁,E-mail:huyan@fudan.edu.cn作者简介:
荆凤:女,本科(博士在读),E-mail:21111170001@m.fudan.edu.cn
基金资助:
JING Feng(), WANG Yuanyuan, XING Weijie, XU Lei, HU Yan()
Received:
2022-08-23
Online:
2023-04-10
Published:
2023-04-11
摘要:
目的 系统检索、评价并总结国内外关于乳腺癌患者芳香化酶抑制剂诱导的骨关节症状预防和管理的最佳证据。 方法 系统检索国内外相关指南网站及专业协会网站、Cochrane Library、澳大利亚乔安娜布里格斯研究所循证卫生保健中心数据库、PubMed、Web of Science核心集、Embase、CINAHL、中国知网、维普数据库、万方数据库、中国生物医学文献数据库中所有关于乳腺癌患者芳香化酶抑制剂诱导的骨关节症状预防及管理的指南、专家共识、系统评价、Meta分析、最佳实践、推荐实践,检索时限为建库至2022年7月12日。由2名研究者独立进行文献质量评价和资料提取。 结果 共纳入21篇文献,其中循证指南1篇、共识指南3篇、系统评价或Meta分析17篇,从骨关节症状的发病率、临床表现、症状评估、风险评估、预防措施、药物干预、非药物干预、管理策略8个方面总结出37条最佳证据,其中有17条1级证据。 结论 乳腺癌患者芳香化酶抑制剂诱导的骨关节症状预防和管理的最佳证据可以为临床医护人员制订相关症状管理方案和开展临床实践提供参考,但仍需结合临床情境和患者意愿选择适宜的证据应用于临床实践。
荆凤, 王园园, 邢唯杰, 徐蕾, 胡雁. 乳腺癌患者芳香化酶抑制剂诱导的骨关节症状预防和管理的证据总结[J]. 中华护理杂志, 2023, 58(7): 808-815.
JING Feng, WANG Yuanyuan, XING Weijie, XU Lei, HU Yan. Evidence summary of the prevention and management in breast cancer patients for aromatase inhibitors-induced musculoskeletal symptoms[J]. Chinese Journal of Nursing, 2023, 58(7): 808-815.
[1] |
Roberts K, Rickett K, Greer R, et al. Management of aromatase inhibitor induced musculoskeletal symptoms in postmenopausal early breast cancer:a systematic review and Meta-analysis[J]. Crit Rev Oncol/Hematol, 2017, 111:66-80.
DOI URL |
[2] |
Marta PM, Sonia S, Ignasi T, et al. Assessment of early therapy discontinuation and health-related quality of life in breast cancer patients treated with aromatase inhibitors:B-ABLE cohort study[J]. Breast Cancer Res Treat, 2019, 177(1):53-60.
DOI |
[3] | 彭楠, 于明薇, 王笑民. 芳香化酶抑制剂相关骨关节症状的研究进展[J]. 中国肿瘤临床, 2015, 42(21):1067-1070. |
Peng N, Yu MW, Wang XM. Research progress on aromatase inhibitor-associated musculoskeletal symptoms[J]. Chin J Clin Oncol, 2015, 42(21):1067-1070. | |
[4] |
Beckwee D, Leysen L, Meuwis K, et al. Prevalence of aromatase inhibitor-induced arthralgia in breast cancer:a systematic review and Meta-analysis[J]. Support Care Cancer, 2017, 25(5):1673-1686.
DOI URL |
[5] |
Lopez C, Charles C, Rouby P, et al. Relations between arthralgia and fear of recurrence:results of a cross-sectional study of breast cancer patients treated with adjuvant aromatase inhibitors therapy[J]. Support Care Cancer, 2015, 23(12):3581-3588.
DOI URL |
[6] | Hadji P, Aapro MS, Body JJ, et al. Management of aromatase inhibitor-associated bone loss(AIBL) in postmenopausal women with hormone sensitive breast cancer:joint position statement of the IOF,CABS,ECTS,IEG,ESCEO,IMS,and SIOG[J]. J Bone Oncol, 2017, 7(C):1-12. |
[7] | 中国乳腺癌内分泌治疗多学科管理骨安全共识专家组. 绝经后早期乳腺癌芳香化酶抑制剂治疗相关的骨安全管理中国专家共识[J]. 中华肿瘤杂志, 2015, 37(7):554-558. |
Consensus Expert Group on Bone Safety in Multidisciplinary Management of Endocrine Therapy for Breast Cancer in China. Chinese expert consensus on bone safety management related to aromatase inhibitor treatment of early postmenopausal breast cancer[J]. Chin J Oncol, 2015, 37(7):554-558. | |
[8] |
荆凤, 邢唯杰. 乳腺癌患者内分泌治疗相关症状及非药物干预的研究进展[J]. 中华护理杂志, 2021, 56(4):635-640.
DOI |
Jing F, Xing WJ. Review of symptoms and non-pharmacological interventions among breast cancer survivors undergoing adjuvant endocrine therapy[J]. Chin J Nurs, 2021, 56(4):635-640.
DOI |
|
[9] |
Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ:advan-cing guideline development,reporting and evaluation in health care[J]. CMAJ, 2010, 182(18):E839-E842.
DOI URL |
[10] | 胡雁, 郝玉芳. 循证护理学[M]. 2版. 北京: 人民卫生出版社, 2018:77. |
Hu Y, Hao YF. Evidence-based nursing[M]. 2nd ed. Beijing: People’s Medical Publishing House, 2018:77. | |
[11] | 顾莺, 张慧文, 周英凤, 等. JBI循证卫生保健中心关于不同类型研究的质量评价工具:系统评价的方法学质量评价[J]. 护士进修杂志, 2018, 33(8):701-703. |
Gu Y, Zhang HW, Zhou YF, et al. JBI evidence-based health center’s quality assessment tool for different types of research:the quality evaluation of systematic reviews[J]. J Nurses Train, 2018, 33(8):701-703. | |
[12] | 王春青, 胡雁. JBI证据预分级及证据推荐级别系统(2014版)[J]. 护士进修杂志, 2015, 30(11):964-967. |
Wang CQ, Hu Y. JBI evidence pre-classification and evidence rank system(2014 edition)[J]. J Nurses Train, 2015, 30(11):964-967. | |
[13] | Cancer Australia. Guidance for the management of early breast cancer. Recommendations and practice points[EB/OL]. (2020-09-01) [2022-08-22]. https://www.canceraustralia.gov.au/publi-cations-and-resources/cancer-australia-publications/guidance-mana gement-early-breast-cancer-recommendations-and-practice-points. |
[14] |
Jame A, Humberto C, Robert C, et al. Endocrine therapy and related issues in hormone receptor-positive early breast cancer:a roundtable discussion by the breast cancer therapy expert group(BCTEG)[J]. Breast Cancer Res Treat, 2018, 169(1):1-7.
DOI |
[15] |
Marsden J, Marsh M, Rigg A. British Menopause Society consensus statement on the management of estrogen deficiency symptoms,arthralgia and menopause diagnosis in women treated for early breast cancer[J]. Post Reprod Health, 2019, 25(1):21-32.
DOI PMID |
[16] | 国家肿瘤质控中心乳腺癌专家委员会, 北京乳腺病防治学会健康管理专业委员会. 中国乳腺癌随诊随访与健康管理指南(2022版)[J]. 中华肿瘤杂志, 2022, 44(1):1-28. |
Breast Cancer Expert Committee of National Cancer Quality Control Center, Health Management Professional Committee of Beijing Breast Cancer Prevention and Control Society. Com-prehensive management guideline for breast cancer follow-up and healthcare(2022 edition)[J]. Chin J Oncol, 2022, 44(1):1-28. | |
[17] | Liu X, Lu J, Wang G, et al. Acupuncture for arthralgia induced by aromatase inhibitors in patients with breast cancer:a systematic review and Meta-analysis[J]. Integr Cancer Ther, 2021, 20:1-14. |
[18] | Chung KY, Ho G, Novak CB, et al. Aromatase inhibitor-induced carpal tunnel syndrome and stenosing tenosynovitis:a systematic review[J]. Plast Reconstr Surg, 2022, 149(3):445e-452e. |
[19] | Dowling M, McDonagh B, Meade E. Arthralgia in breast cancer survivors:an integrative review of endocrine therapy[J]. Oncol Nurs Forum, 2017, 44(3):337-349. |
[20] |
Chen L, Lin CC, Huang TW, et al. Effect of acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer:a Meta-analysis of randomized controlled trials[J]. Breast, 2017, 33:132-138.
DOI URL |
[21] |
Lu G, Zheng J, Zhang L. The effect of exercise on aromatase inhibitor-induced musculoskeletal symptoms in breast cancer survivors:a systematic review and Meta-analysis[J]. Support Care Cancer, 2020, 28(4):1587-1596.
DOI |
[22] |
Poo CL, Dewadas HD, Ng FL, et al. Effect of traditional Chinese medicine on musculoskeletal symptoms in breast cancer:a systematic review and Meta-analysis[J]. J Pain Symptom Manage, 2021, 62(1):159-173.
DOI URL |
[23] |
Boing L, Vieira MCS, Moratelli J, et al. Effects of exercise on physical outcomes of breast cancer survivors receiving hormone therapy:a systematic review and Meta-analysis[J]. Maturitas, 2020, 141:71-81.
DOI URL |
[24] |
Chan CWH, Tai D, Kwong S, et al. The effects of pharmacological and non-pharmacological interventions on symptom management and quality of life among breast cancer survivors undergoing adjuvant endocrine therapy:a systematic review[J]. Int J Environ Res Public Health, 2020, 17(8):2950.
DOI URL |
[25] |
Nahm N, Mee S, Marx G. Efficacy of management strategies for aromatase inhibitor-induced arthralgia in breast cancer patients:a systematic review[J]. Asia Pac J Clin Oncol, 2018, 14(6):374-382.
DOI URL |
[26] | Roberts KE, Rickett K, Feng S, et al. Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer[J]. Cochrane Data-base Syst Rev, 2020, 1:CD012988. |
[27] |
Hong D, Bi L, Zhou J, et al. Incidence of menopausal symptoms in postmenopausal breast cancer patients treated with aromatase inhibitors[J]. Oncotarget, 2017, 8(25):40558-40567.
DOI PMID |
[28] |
Yang GS, Kim HJ, Griffith KA, et al. Interventions for the treatment of aromatase inhibitor-associated arthralgia in breast cancer survivors:a systematic review and Meta-analysis[J]. Cancer Nurs, 2017, 40(4):E26-E41.
DOI URL |
[29] | Chan YT, Wang N, Tam CW, et al. Systematic review with Meta-analysis:effectiveness and safety of acupuncture as adjuvant therapy for side effects management in drug therapy-receiving breast cancer patients[J]. Evid Based Complement Al-ternat Med, 2021, 2021:9949777. |
[30] | Roberts KE, Adsett IT, Rickett K, et al. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer[J]. Cochrane Data-base Syst Rev, 2022, 1(1):Cd013167. |
[31] |
Kim TH, Kang JW, Lee TH. Therapeutic options for aromatase inhibitor-associated arthralgia in breast cancer survivors:a systematic review of systematic reviews,evidence mapping,and network Meta-analysis[J]. Maturitas, 2018, 118:29-37.
DOI URL |
[32] | Hyder T, Marino CC, Ahmad S, et al. Aromatase inhibitor-associated musculoskeletal syndrome:understanding mechanisms and management[J]. Front Endocrinol(Lausanne), 2021, 12:713700. |
[33] | Arjun G, Lynn HN, Loprinzi CL. Management of aromatase inhibitor-induced musculoskeletal symptoms[J]. JCO Oncol Pract, 2020, 16(11):OP2000113. |
[34] | 朱叶卉, 胡雁, 吴密彬, 等. 电话随访对乳腺癌患者服药依从性和生活质量的影响[J]. 中华护理杂志, 2015, 50(1):69-73. |
Zhu YH, Hu Y, Wu MB, et al. Effect of nurse-led follow-up on medication adherence and quality of life of patients with breast cancer[J]. Chin J Nurs, 2015, 50(1):69-73. | |
[35] | 王春青, 胡雁, 吴密彬, 等. 乳腺癌患者内分泌治疗服药监控平台的设计及应用[J]. 中华护理杂志, 2017, 52(3):261-266. |
Wang CQ, Hu Y, Wu MB, et al. The effectiveness of computer-based monitoring system for patients with breast cancer receiving adjuvant hormonal therapy[J]. Chin J Nurs, 2017, 52(3):261-266. |
[1] | 郭员志, 张红梅, 赵培, 王琦, 李玉环, 王淑芬, 于洋. 乳腺癌术后淋巴水肿预防与护理的循证实践[J]. 中华护理杂志, 2023, 58(7): 773-780. |
[2] | 武佩佩, 王盈, 沈傲梅, 强万敏, 杨惠莉, 刘鑫鑫. 乳腺癌相关淋巴水肿患者综合消肿治疗依从性的质性研究[J]. 中华护理杂志, 2023, 58(7): 781-787. |
[3] | 何丽, 胡露红, 崔金锐, 邓妍, 褚彦香, 王玮荻, 王倩云. 乳腺癌化疗患者自我倡权能力现状及影响因素分析[J]. 中华护理杂志, 2023, 58(7): 788-793. |
[4] | 刘英, 甄倩, 王晓庄, 张皎霄, 张亚平, 王德欣, 王熙棋. 乳腺癌患者和配偶的创伤后成长及与积极心理资本的关系[J]. 中华护理杂志, 2023, 58(7): 794-799. |
[5] | 吴媛, 张玉玺, 王楠楠, 张慧超. 乳腺癌患者参与同伴支持体验质性研究的Meta整合[J]. 中华护理杂志, 2023, 58(7): 800-807. |
[6] | 周彦君, 李秋月, 胡宇乐, 杨浩杰, 赵芳, 梁涛. 乳腺癌蒽环类化疗相关心脏毒性早期识别及预防的研究进展[J]. 中华护理杂志, 2023, 58(7): 816-821. |
[7] | 谢琼华, 骆尹, 郝富杰, 姜懿珊, 郭爱敏. 慢性阻塞性肺疾病患者家庭呼吸康复护理的最佳证据总结[J]. 中华护理杂志, 2023, 58(7): 857-863. |
[8] | 马喜宁, 白艳娟, 孔思铭, 黄蓉, 张静, 姚辉. 强直性脊柱炎患者运动指导方案的最佳证据总结[J]. 中华护理杂志, 2023, 58(7): 864-870. |
[9] | 蒋璐璐, 王喜益, 徐洁慧, 邬燕伟, 胡韵. 智能交互式护理信息支持系统的构建及在乳腺癌患者中的应用研究[J]. 中华护理杂志, 2023, 58(6): 654-661. |
[10] | 吴傅蕾, 袁长蓉, 杨瑒, 尚美美, 闫荣, 郑叶平, 钮美娥, 黄青梅. 乳腺癌患者化疗期症状群困扰风险预测模型的构建与评价[J]. 中华护理杂志, 2023, 58(6): 676-681. |
[11] | 单雪琪, 余姜璇, 王俊杰, 许娅文, 沈睿, 王茜茜. 膝骨关节炎患者自我管理的最佳证据总结[J]. 中华护理杂志, 2023, 58(6): 735-742. |
[12] | 张静, 梁士楚, 陈忠兰. 护理领域中临床实践指南依从性的研究进展[J]. 中华护理杂志, 2023, 58(6): 758-762. |
[13] | 葛伟婷, 徐柳燕, 方思岚, 袁凤琴. 急性呼吸道传染病患者经鼻高流量氧疗期间医院感染防控的最佳证据总结[J]. 中华护理杂志, 2023, 58(5): 544-551. |
[14] | 陈婧怡, 胡荣, 王滨滨, 李张杰. 造血干细胞移植患者疲乏管理的最佳证据总结[J]. 中华护理杂志, 2023, 58(5): 609-616. |
[15] | 赵燕利, 赵伟, 刘志华, 徐晖, 刘东玲. 安全病房干预在精神科应用的范围综述[J]. 中华护理杂志, 2023, 58(5): 624-630. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||